86 related articles for article (PubMed ID: 9425876)
1. Effects of switching from Depakene to generic valproic acid on individuals with mental retardation.
Vadney VJ; Kraushaar KW
Ment Retard; 1997 Dec; 35(6):468-72. PubMed ID: 9425876
[TBL] [Abstract][Full Text] [Related]
2. Effects on individuals with mental retardation of changing Depakote to Depakene.
Vadney V; Ricketts RW; Cole RW
Ment Retard; 1994 Oct; 32(5):341-6. PubMed ID: 7984119
[TBL] [Abstract][Full Text] [Related]
3. Comment on Vadney and Kraushaar's "Effect of switching from Depakene to generic valproic acid on individuals with mental retardation".
Alvarez N; Williams R
Ment Retard; 1998 Aug; 36(4):330-1. PubMed ID: 9713191
[No Abstract] [Full Text] [Related]
4. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
[TBL] [Abstract][Full Text] [Related]
5. Update on the costs of Depakote and Depakene.
Feldstein JH; Curtis JL
Ment Retard; 1995 Feb; 33(1):62. PubMed ID: 7707942
[No Abstract] [Full Text] [Related]
6. Non-equivalence of bioavailability between generic and branded form of sodium valproate.
Dhanaraj M; Jayavelu A
Neurol India; 2004 Sep; 52(3):398. PubMed ID: 15472447
[No Abstract] [Full Text] [Related]
7. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs.
Bautista RE; Gonzales W; Jain D
Epilepsy Res; 2011 Jun; 95(1-2):158-67. PubMed ID: 21530177
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation.
Kastner T; Finesmith R; Walsh K
J Clin Psychopharmacol; 1993 Dec; 13(6):448-51. PubMed ID: 8120159
[TBL] [Abstract][Full Text] [Related]
9. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
Pierre-Louis SJ; Brannegan RT; Evans AT
Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
[TBL] [Abstract][Full Text] [Related]
10. The effects of antiepileptic medications on the social skills of individuals with mental retardation.
Matson JL; Luke MA; Mayville SB
Res Dev Disabil; 2004; 25(2):219-28. PubMed ID: 15026096
[TBL] [Abstract][Full Text] [Related]
11. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
Fitzgerald CL; Jacobson MP
Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
[TBL] [Abstract][Full Text] [Related]
12. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
13. Different serum concentrations of steady-state valproic acid in two sustained-release formulations.
Yasui-Furukori N; Saito M; Nakagami T; Niioka T; Sato Y; Fujii A; Kaneko S
Psychiatry Clin Neurosci; 2007 Jun; 61(3):308-12. PubMed ID: 17472600
[TBL] [Abstract][Full Text] [Related]
14. Valproate in the treatment of epilepsy in people with intellectual disability.
Friis ML
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
[TBL] [Abstract][Full Text] [Related]
15. [Acute Intermittent porphyria and valproic acid].
Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
[No Abstract] [Full Text] [Related]
16. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
Gu J; Huang Y
Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
[TBL] [Abstract][Full Text] [Related]
17. Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.
Sagot-Lerolle N; Lamine A; Chaix ML; Boufassa F; Aboulker JP; Costagliola D; Goujard C; Pallier C; Delfraissy JF; Lambotte O;
AIDS; 2008 Jun; 22(10):1125-9. PubMed ID: 18525257
[TBL] [Abstract][Full Text] [Related]
18. The use of generic medication in epilepsy: a review of potential issues and challenges.
Van Paesschen W; Hauman H; Lagae L
Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
[TBL] [Abstract][Full Text] [Related]
19. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
Ozaydin E; Yükselgüngör H; Köse G
Eur J Paediatr Neurol; 2008 Mar; 12(2):141-3. PubMed ID: 17881258
[TBL] [Abstract][Full Text] [Related]
20. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
